Showing results (231-240 of 243) with videos related to

Sort By:
Pageof 25
Blood|December 14, 2023
A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimeticsRomane Durand, Géraldine Descamps, Céline Bellanger, et al.
The Journal of Pediatrics|August 31, 2025
Temporal Trends in Red Blood Cell and Platelet Transfusion Thresholds for Extremely Low Birth Weight InfantsRavi M Patel, Jeanne E Hendrickson, Rebecca Birch, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|April 26, 2026
Guideline No XX: Clinical Management of EndometriosisPaul J Yong, Catherine Allaire, Mohamed Bedaiwy, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|April 26, 2026
LIGNES DIRECTRICES DE PRATIQUE CLINIQUE DE LA SOGC N° XX : Prise en charge clinique de l'endométriosePaul J Yong, Catherine Allaire, Mohamed Bedaiwy, et al.
Journal of Minimally Invasive Gynecology|January 21, 2021
Technicity in Canada: A Nationwide Whole-Population Analysis of Temporal Trends and Variation in Minimally Invasive HysterectomiesInnie Chen, Ranjeeta Mallick, Catherine Allaire, et al.
Blood|September 8, 2020
A prospective, blinded study of a PF4-dependent assay for HIT diagnosisBethany Samuelson Bannow, Deepti M Warad, Curtis G Jones, et al.
Biology of the Cell|November 9, 2024
CRCI2NA inaugural symposium: A meeting on tumor and immune ecosystemsVincent J Guen, Gwennan André-Grégoire, Céline Beauvillain, et al.
Transfusion|March 30, 2023
Associations between ABO non-identical platelet transfusions and patient outcomes-A multicenter retrospective analysisDaniel W Bougie, Sarah E Reese, Rebecca J Birch, et al.
JAMA Network Open|June 24, 2026
Red Blood Cell Transfusion Characteristics and Morbidity or Mortality in Very-Low-Birth-Weight InfantsJeanne E Hendrickson, Rebecca J Birch, Elizabeth A K Rowley, et al.
The Journal of Experimental Medicine|July 27, 2016
BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic miceMohamed-Amine Hamouda, Arnaud Jacquel, Guillaume Robert, et al.
Pageof 25